Berkeley Defends Bid To Overrule PTAB In CRISPR Row

Researchers from the University of California, Berkeley and the University of Vienna fended off pointed questioning Monday from a Federal Circuit panel on their effort to nix a patent for gene-editing technology CRISPR-Cas9, held by the Massachusetts-based Broad Institute.